Recommended Paediatric Thesis Topics on Thalassemia
The most impactful paediatric thesis topics on thalassemia should focus on cardiovascular complications, endocrine dysfunction, or novel therapeutic approaches, as these directly affect mortality, morbidity, and quality of life in children with thalassemia major.
High-Priority Research Areas Based on Current Evidence
1. Cardiac Iron Overload and Early Detection
Cardiac disease remains the predominant cause of death in β-thalassemia major 1. A thesis could investigate:
Early cardiac T2 MRI screening protocols in children*: The evidence shows cardiac iron loading can occur as early as 7 years of age, though typically after 10 years 1. Research examining optimal screening initiation age and frequency in pediatric populations would be highly relevant.
Cardiac dysfunction prevention strategies: Since cardiac disease is easier and safer to treat at early stages rather than late stages when mortality risk is high 1, investigating preventive chelation protocols specifically tailored to cardiac protection in children would address a critical gap.
Arrhythmia risk stratification in pediatric patients: Approximately 14% of patients with severe iron overload (T2* <6 ms) experience arrhythmias within one year 1, with 50% developing cardiac rhythm disturbances by age 20 1. A pediatric-focused study on early arrhythmia detection would be valuable.
2. Endocrine Complications in Children and Adolescents
Endocrine dysfunction represents a major source of morbidity affecting quality of life 2, 3. Promising thesis directions include:
Growth failure and delayed puberty: Hypogonadism and delayed growth are common in transfusion-dependent thalassemia, with local data showing stunted growth in 50.5% and hypogonadism/delayed puberty in 45.8% of patients 3. Research on early intervention strategies or predictive biomarkers would be clinically significant.
Screening protocol optimization for resource-limited settings: The 2025 International Consensus Guideline recommends screening before age 10 in transfusion-dependent patients 2. A thesis could develop and validate simplified screening algorithms for low-resource environments 3.
Bone health in pediatric thalassemia: Low bone density affects 14.8% of patients, with osteopenia and osteoporosis documented even in younger populations 4. Investigating preventive strategies or the relationship between chelation regimens and bone mineralization would address an understudied area.
3. Nutritional Status and Micronutrient Deficiencies
Micronutrient deficiencies are highly prevalent and potentially modifiable 4:
Vitamin D, selenium, and folate supplementation protocols: With deficiency rates of 72.4% for vitamin D and selenium, and 37.9% for folate 4, research on optimal supplementation strategies and their impact on growth, bone health, and overall outcomes would be practical and impactful.
Relationship between nutritional status and complications: The lack of significant correlation between ferritin levels and micronutrient status 4 suggests complex interactions worthy of investigation.
4. Novel Therapeutic Approaches in Pediatric Populations
Recent therapeutic advances require pediatric-specific evaluation 5:
Luspatercept efficacy and safety in children: While approved for adults with β-thalassemia, pediatric data are limited 5. A thesis could contribute to understanding its role in younger patients.
Gene therapy outcomes in adolescents: Gene therapy with betibeglogene autotemcel is approved for patients ≥12 years old 5. Research on long-term outcomes, quality of life improvements, or patient selection criteria would be timely.
Comparative effectiveness of iron chelation regimens: Evidence shows deferiprone superiority over deferoxamine for cardiac iron removal, and combined therapy superiority over monotherapy 1. Pediatric-specific studies on adherence, side effects, and optimal regimen selection would be valuable.
5. Pregnancy and Reproductive Health in Adolescent Females
Fertility and pregnancy outcomes require specialized management 1:
Transition of care for adolescent females: Research on preparing adolescent females for future pregnancy, including cardiac T2* assessment protocols and fertility preservation strategies, would address an emerging need as survival improves.
Impact of early chelation optimization on reproductive outcomes: Since maternal risks depend primarily on preexisting organ damage 1, investigating how pediatric management affects future reproductive health would be forward-thinking.
6. Quality of Life and Disability Assessment
Thalassemia's impact extends beyond clinical parameters 6:
Disability risk assessment in pediatric populations: The proposed DRAM-Thal model considers both clinical and social parameters 6. Validating or adapting this model for children would contribute to holistic care approaches.
Psychosocial outcomes and school performance: Research examining the relationship between treatment burden, complications, and educational/social outcomes would address quality of life comprehensively.
Methodological Considerations
For maximum impact, prioritize:
- Prospective cohort designs for natural history studies
- Randomized controlled trials for therapeutic interventions (where ethical)
- Multi-center collaborations to achieve adequate sample sizes in this relatively rare disease
- Patient-reported outcomes alongside clinical endpoints
- Cost-effectiveness analyses particularly relevant for resource-limited settings
Common Pitfalls to Avoid
- Avoid purely descriptive studies without actionable clinical implications
- Don't ignore transfusion-dependent vs. non-transfusion-dependent distinctions - complications differ significantly 1, 2
- Consider local epidemiology - thalassemia prevalence and healthcare resources vary dramatically by region 1
- Don't overlook the transition period from pediatric to adult care, which represents a vulnerable time for complications
The strongest thesis topics will address gaps in mortality reduction, complication prevention, or quality of life improvement, with particular emphasis on early intervention strategies that can alter the disease trajectory before irreversible organ damage occurs.